NovaBay Pharmaceutical receives notice of allowance Antiinfectives CNV-612 and related compounds EMERYVILLE, Calif. – NovaBay Pharmaceuticals, Inc. announced today it has received a notice of allowance from the Patent and Trademark Office a patent application for a broad portfolio of anti-infective compounds, including CNV-612.
My ONE favorite (and most effective) acne product.